Blog dermatologico

Elenco degli articoli con argomento «dermatite atopica»

Subtypes of atopic dermatitis

Subtypes of atopic dermatitis

Ricerca

Atopic dermatitis (AD) is a heterogenous disorder and can be classified into different types....

Leggi tutto
Contact allergy in children with and without atopic dermatitis

Contact allergy in children with and without atopic dermatitis

Ricerca

Contact allergy and atopic dermatitis (AD) are both common inflammatory T cell-mediated diseases and many factors may influence the prevalence of contact allergy in AD patients...

Leggi tutto
Moderate-to-severe atopic dermatitis in adolescents

Moderate-to-severe atopic dermatitis in adolescents

Ricerca

Moderate-to-severe atopic dermatitis (AD) in the adolescence is a high burden disease and its treatment can be very challenging...

Leggi tutto
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis

Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis

Ricerca

Primary results from the Measure Up 1 and Measure Up 2 studies demonstrated upadacitinib efficacy and safety through 16 weeks in patients with atopic dermatitis....

Leggi tutto
Increased expression of Filaggrin and Claudin-1 in the ocular surface

Increased expression of Filaggrin and Claudin-1 in the ocular surface

Ricerca

Atopic dermatitis (AD) is an itchy, chronic and inflammatory skin condition, with dysfunctional immune response and skin barrier defects....

Leggi tutto
The Impact of Childhood Atopic Dermatitis

The Impact of Childhood Atopic Dermatitis

Ricerca

The Impact of Childhood Atopic Dermatitis on Life Decisions for Caregivers and Families...

Leggi tutto
Atopic dermatitis associated with autoimmune, cardiovascular and mental health comorbidities

Atopic dermatitis associated with autoimmune, cardiovascular and mental health comorbidities

Ricerca

Previous studies have reported conflicting estimates of associations between atopic dermatitis (AD) and autoimmune, cardiovascular and mental health comorbidities....

Leggi tutto
Psoriasi e dermatite atopica indicazioni dei dermatologi

Psoriasi e dermatite atopica indicazioni dei dermatologi

Rassegna stampa

Le nuove chances terapeutiche per eliminare le lesioni cutanee e mitigare il prurito, al centro della seconda giornata di lavori del Congresso della Società Italiana di Dermatologia e delle Malattie Sessualmente Trasmesse....

Leggi tutto
Phase 2a randomized clinical trial of dupilumab

Phase 2a randomized clinical trial of dupilumab

Ricerca

Treatments for alopecia areata (AA) patients with extensive scalp hair loss are limited...

Leggi tutto
Improvement in symptoms of anxiety and depression in patients

Improvement in symptoms of anxiety and depression in patients

Ricerca

Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib...

Leggi tutto
Feelings of guilt in parents of children with atopic dermatitis

Feelings of guilt in parents of children with atopic dermatitis

Ricerca

Feelings of guilt may be associated with illness. Patients may feel responsible for their disease...

Leggi tutto
The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases

The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases

Ricerca

Allergic diseases are significant diseases that affect many patients worldwide....

Leggi tutto
Once-daily upadacitinib versus placebo in adolescents and adults

Once-daily upadacitinib versus placebo in adolescents and adults

Ricerca

Upadacitinib is an oral Janus kinase (JAK) inhibitor with greater inhibitory potency for JAK1 than JAK2, JAK3, and tyrosine kinase 2....

Leggi tutto
Atopic Dermatitis and Infertility

Atopic Dermatitis and Infertility

Ricerca

Given that common pathophysiological factors play a role in atopic dermatitis (AD) and infertility...

Leggi tutto
Impact of baricitinib in combination with topical steroids

Impact of baricitinib in combination with topical steroids

Ricerca

Baricitinib is an oral, selective, reversible Janus kinase 1/2 inhibitor approved in the European Union and Japan and under investigation in the United States for treatment of atopic dermatitis (AD)....

Leggi tutto
Tralokinumab for atopic dermatitis

Tralokinumab for atopic dermatitis

Ricerca

Tralokinumab for atopic dermatitis...

Leggi tutto
Biomarkers in atopic dermatitis

Biomarkers in atopic dermatitis

Ricerca

Atopic dermatitis (AD) is a common yet complex skin disease, posing a therapeutic challenge with increasingly recognized different phenotypes among variable patient populations....

Leggi tutto
Note informative per i pazienti - vaccini anti SARS-COV-2 in Italia
A 48-week update

A 48-week update

Ricerca

A 48-week update of a multicentre real-life experience of dupilumab in adult patients...

Leggi tutto
A Short Cycle of Narrow-Band UVB

A Short Cycle of Narrow-Band UVB

Ricerca

Since the best clinical response to dupilumab is achieved after 12-16 weeks...

Leggi tutto

Risultati da 1 a 20 di 138